Spire Healthcare Group plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPI.L research report →
Companywww.spirehealthcare.com
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
- CEO
- Justinian Joseph Ash
- IPO
- 2014
- Employees
- 15,703
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $891.33M
- P/E
- 54.38
- P/S
- 0.56
- P/B
- 1.20
- EV/EBITDA
- 9.15
- Div Yield
- 0.67%
Profitability
- Gross Margin
- 41.55%
- Op Margin
- 8.26%
- Net Margin
- 1.04%
- ROE
- 2.22%
- ROIC
- 5.64%
Growth & Income
- Revenue
- $1.58B · 4.54%
- Net Income
- $16.40M · -35.43%
- EPS
- $0.04 · -34.92%
- Op Income
- $142.90M
- FCF YoY
- 15.70%
Performance & Tape
- 52W High
- $256.50
- 52W Low
- $140.80
- 50D MA
- $165.49
- 200D MA
- $197.70
- Beta
- 0.91
- Avg Volume
- 2.53M
Get TickerSpark's AI analysis on SPI.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SPI.L Coverage
We haven't published any research on SPI.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SPI.L Report →